Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

{ "Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes", "This study is looking for adults aged 18-90 with type 2 diabetes whose blood sugar levels (HbA1c) are not well-controlled, even with medication. The goal is to find the best way to help people manage their diabetes. You would be assigned to one of four groups: receiving usual care, getting extra medicine management support from a pharmacist, receiving support from a Community Health Worker (CHW) to help with life challenges affecting your health, or getting both pharmacist and CHW support. Researchers will measure changes in your HbA1c levels over 6 and 12 months to see which approach works best. We are currently unsure of the study's recruitment status.", "design": "This interventional study plans to enroll 376 participants and will randomly assign them to one of four groups.", "commitments": "Participants will have one 60-minute session and at least four 30-minute follow-up sessions with a pharmacist, or one 30-minute phone call and a 2-hour session with a Community Health Worker, or both, over 6 months.", "compensation": "Not stated in the trial record.", "follow_up": "Your blood sugar levels (HbA1c) will be measured at 6 months and 12 months after starting the study.", }

Study design
Not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05912647

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

Recruiting
NAAges 18–90InterventionalHealth services
University of Wisconsin, Madison
~376 participants
Updated 2026-07-23 on ClinicalTrials.gov
What's tested:MTMCHW

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in mean hemoglobin A1c score
Measured over Baseline to 6 months
+1 more outcome measured
Diabetes
Diabetes Type 2
1 sites across 1 states
Wisconsin1
  • Michelle Chui, PharmD, PhD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Men and women ages 18-90 with diagnosed type 2 diabetes who speak and understand English or Spanish.
Taking at least one oral or injectable diabetes medication
HbA1c ≥ 7.5% based on point of care test.
Will reside in the geographical area throughout the study period.
Have access to a phone during the study period.
Willing to attend all orientation/training sessions.

Exclusion

Having a caregiver who is the main decision maker in self-management.
Participating in another lifestyle, or medication adherence program.
Participated in standard MTM/MTM-related intervention in the last 6 months.
Women who are pregnant or plan to get pregnant in the next 6 months.
  • Change in mean hemoglobin A1c scoreBaseline to 6 months

    HbA1c will be measured, and the mean change will be compared across arms

  • Change in mean hemoglobin A1c scoreBaseline to 12 months

    HbA1c will be measured, and the mean change will be compared across arms